BioSpace News Archive

Synpromics Promoter Technology Moves Closer to the Clinic

Synpromics is pleased to announce positive data presented today by a key partner, uniQure (NASDAQ:QURE), at the European Society of Gene and Cell Therapy conference in Lausanne, Switzerland.

October 18, 2018
·
2 min read
Drug Development

Rocket Pharmaceuticals Presents Updated Long-Term Phase 1/2 Clinical Data of RP-L102 in Fanconi Anemia Patients at the 2018 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT)

RP-L102 Continues to Demonstrate Increasing and Durable Engraftment (Peripheral Vector Copy Number) In Fanconi Anemia Patients for Up to Thirty Months with First-Generation Process

October 18, 2018
·
8 min read
Business

RTI Surgical® Schedules Third Quarter 2018 Earnings Call for November 1, 2018

RTI will host a conference call and simultaneous audio webcast to discuss third quarter 2018 results at 9:00 a.m. ET the same day.

October 18, 2018
·
2 min read
BioForest

Pace International Launches New Edible Fruit Coating

The first of its kind, PrimaFresh 606 GL is made with natural food-grade ingredients meeting the most stringent requirements from retailers around the world

October 18, 2018
·
2 min read
Business

Spectrum Pharmaceuticals Announces Dr. Francois Lebel as Chief Medical Officer

Veteran of the Biopharmaceutical Industry Joins as Company Advances Two Late-stage Oncology Therapies

October 18, 2018
·
5 min read
Can-Fite CEO to present as Expert Speaker on Namodenoson at NASH Summit Europe 2018

Dr. Pnina Fishman, will join other global thought-leaders in the field of non-alcoholic steatohepatitis (NASH) to speak at NASH Summit Europe in Frankfurt, Germany on October 22, 2018.

October 18, 2018
·
5 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) in Combination with Pfizer’s Inlyta® (axitinib) Significantly Improved Overall Survival (OS) and Progression-free Survival (PFS) as First-Line Therapy for Advanced or Metastatic Renal Cell Carcinoma

KEYTRUDA is First Anti-PD-1 Therapy in Combination to Improve Both OS and PFS in Advanced or Metastatic RCC, the Most Common Type of Kidney Cancer

October 18, 2018
·
25 min read
Business

CannTrust and Kindred Launch Sales Team in Canadian Recreational Cannabis Market

Kindred to represent CannTrust products under exclusive agreement

October 18, 2018
·
6 min read
Business

New Sun Nuclear Solutions on Display at ASTRO 2018 Meeting

SunCHECK™ Plan-Checking, 3D SCANNER™ Halcyon™ Kit, MICRO+™ MR, MultiPHAN™ Alignment Cube, and More

October 18, 2018
·
2 min read
Aurora Cannabis to Commence Trading on the NYSE

Aurora’s shares will trade on the NYSE under ticker symbol “ACB”, the same symbol the Company’s common shares currently, and will continue to, trade under on the Toronto Stock Exchange

October 18, 2018
·
5 min read